Nurix Therapeutics (NRIX) Stock Price Target 2026

The average analyst price target for Nurix Therapeutics is $32.35, 114.7% above the current price. Of 18 analysts, 17 rate it Buy and 1 Hold. Targets range from $16 to $45. The latest change came on Nov 4, 2026, when Wells Fargo lowered its price target on Nurix Therapeutics from $25 to $20 and kept an Equal-Weight rating.

The Average Analyst Price Target for Nurix Therapeutics is $32.35.

Price Target Range — 11 Quarters

Analyst Consensus — 18 Analysts

17Buy

1Hold

Consensus RatingOutperform# Analysts18Avg. Consensus PT$32.35Upside to Avg. PT+114.7%

Rating Trend — Last 9 Months

Latest Upgrades and Downgrades for Nurix Therapeutics Stock

See all ratings →

Date	Firm	Analyst	Action	Rating Change	Price Target
Nov 4, 2026	Wells Fargo	Derek Archila	PT Cut	Equal-Weight	$25→$20
Oct 16, 2026	HC Wainwright & Co.	Robert Burns	PT Raise	Buy	$34→$36
Oct 13, 2026	RBC Capital	Brian Abrahams	PT Cut	Outperform	$36→$35
Oct 13, 2026	Oppenheimer	Kostas Biliouris	PT Raise	Outperform	$28→$32
Oct 13, 2026	Truist Securities	Gregory Renza	PT Cut	Buy	$34→$33
Oct 13, 2026	Baird	Joel Beatty	PT Raise	Outperform	$33→$36
Oct 13, 2026	Needham	Gil Blum	Maintained	Buy	$34
Aug 10, 2026	RBC Capital	Brian Abrahams	PT Raise	Outperform	$33→$36
Aug 4, 2026	Needham	Gil Blum	Maintained	Buy	$34
Jul 28, 2026	Morgan Stanley	Terence Flynn	PT Raise	Overweight	$36→$38
Jul 22, 2026	UBS	David Dai	PT Raise	Buy	$23→$31
Jul 13, 2026	Mizuho	Joseph Catanzaro	PT Raise	Outperform	$30→$34
Jul 10, 2026	Truist Securities	Gregory Renza	PT Raise	Buy	$32→$34
Jul 10, 2026	RBC Capital	Brian Abrahams	PT Raise	Outperform	$30→$33
Jul 10, 2026	Stifel	Stephen Willey	PT Raise	Buy	$34→$40
Jul 10, 2026	BTIG	Jeet Mukherjee	Maintained	Buy	$32
Jul 10, 2026	Needham	Gil Blum	Maintained	Buy	$34
Jul 10, 2026	HC Wainwright & Co.	Robert Burns	PT Raise	Buy	$32→$34
Jun 18, 2026	Baird	Joel Beatty	PT Raise	Outperform	$26→$33
Jun 15, 2026	Needham	Gil Blum	Maintained	Buy	$34

Analyst Ratings News

PRO
Wells Fargo Maintains Equal-Weight on Nurix Therapeutics, Lowers Price Target to $20

Wells Fargo analyst Derek Archila maintains Nurix Therapeutics (NASDAQ:NRIX) with a Equal-Weight and lowers the price target from $25 to $20.

Benzinga Newsdesk

SpaceX To Rally Around 85%? Here Are 10 Top Analyst Forecasts For Friday

Wall Street analysts raised targets for MSTR, FOXA, NRIX, ZETA and TWLO, while cutting targets for CAMT and DVN.

Avi Kapoor

PRO
HC Wainwright & Co. Maintains Buy on Nurix Therapeutics, Raises Price Target to $36

HC Wainwright & Co. analyst Robert Burns maintains Nurix Therapeutics (NASDAQ:NRIX) with a Buy and raises the price target from $34 to $36.

Benzinga Newsdesk

PRO
RBC Capital Maintains Outperform on Nurix Therapeutics, Lowers Price Target to $35

RBC Capital analyst Brian Abrahams maintains Nurix Therapeutics (NASDAQ:NRIX) with a Outperform and lowers the price target from $36 to $35.

Benzinga Newsdesk

PRO
Oppenheimer Maintains Outperform on Nurix Therapeutics, Raises Price Target to $32

Oppenheimer analyst Kostas Biliouris maintains Nurix Therapeutics (NASDAQ:NRIX) with a Outperform and raises the price target from $28 to $32.

Benzinga Newsdesk

PRO
Truist Securities Maintains Buy on Nurix Therapeutics, Lowers Price Target to $33

Truist Securities analyst Gregory Renza maintains Nurix Therapeutics (NASDAQ:NRIX) with a Buy and lowers the price target from $34 to $33.

Benzinga Newsdesk

Nurix Therapeutics Inc

Nurix Therapeutics (NRIX) Stock Price Target 2026

The Average Analyst Price Target for Nurix Therapeutics is $32.35.

Latest Upgrades and Downgrades for Nurix Therapeutics Stock

Analyst Ratings News

PRO
Wells Fargo Maintains Equal-Weight on Nurix Therapeutics, Lowers Price Target to $20

SpaceX To Rally Around 85%? Here Are 10 Top Analyst Forecasts For Friday

PRO
HC Wainwright & Co. Maintains Buy on Nurix Therapeutics, Raises Price Target to $36

PRO
RBC Capital Maintains Outperform on Nurix Therapeutics, Lowers Price Target to $35

PRO
Oppenheimer Maintains Outperform on Nurix Therapeutics, Raises Price Target to $32

PRO
Truist Securities Maintains Buy on Nurix Therapeutics, Lowers Price Target to $33

People Also Watch

People Also Watch

Nurix Therapeutics Inc

Nurix Therapeutics (NRIX) Stock Price Target 2026

The Average Analyst Price Target for Nurix Therapeutics is $32.35.

Latest Upgrades and Downgrades for Nurix Therapeutics Stock

Analyst Ratings News

PROWells Fargo Maintains Equal-Weight on Nurix Therapeutics, Lowers Price Target to $20

SpaceX To Rally Around 85%? Here Are 10 Top Analyst Forecasts For Friday

PROHC Wainwright & Co. Maintains Buy on Nurix Therapeutics, Raises Price Target to $36

PRORBC Capital Maintains Outperform on Nurix Therapeutics, Lowers Price Target to $35

PROOppenheimer Maintains Outperform on Nurix Therapeutics, Raises Price Target to $32

PROTruist Securities Maintains Buy on Nurix Therapeutics, Lowers Price Target to $33

People Also Watch

People Also Watch

PRO
Wells Fargo Maintains Equal-Weight on Nurix Therapeutics, Lowers Price Target to $20

PRO
HC Wainwright & Co. Maintains Buy on Nurix Therapeutics, Raises Price Target to $36

PRO
RBC Capital Maintains Outperform on Nurix Therapeutics, Lowers Price Target to $35

PRO
Oppenheimer Maintains Outperform on Nurix Therapeutics, Raises Price Target to $32

PRO
Truist Securities Maintains Buy on Nurix Therapeutics, Lowers Price Target to $33